The Science, Honestly
Almost every CBD brand cites research. Almost none mention the trials that found nothing. Learning to spot the difference takes about ten minutes and will save you money — on our products as much as anyone else's.
Search any CBD topic and you will find confident claims backed by "studies." What you will rarely find is the study that came back negative. This article is about reading those claims properly, using a real example where the evidence genuinely points both ways.
The example: topical CBD and joint comfort
This is a well-studied area, and the results genuinely conflict. That makes it a good teacher.
A double-blinded, randomized controlled trial in the Journal of Hand Surgery (2022) tested a topical CBD cream on adults with thumb basal joint discomfort. Over two weeks of twice-daily use, participants reported improvements in pain and function scores compared with a control cream.
A 2023 trial in The Lancet Regional Health found that oral CBD added to acetaminophen did not outperform placebo for knee discomfort. Harvard Health has noted that an earlier topical trial also failed to beat placebo.
Both are real. Both are peer-reviewed. A brand quoting only the first is not lying — it is selecting. That is the thing to watch for.
Five questions to ask about any CBD claim
- Was it topical or oral? These behave very differently in the body. Results from one do not transfer to the other, though marketing often blurs them.
- Was there a placebo group? Without one, you cannot separate the product from the expectation of the product.
- How many people, and for how long? A two-week study of forty people is a signal, not a settled fact.
- What was actually measured? Self-reported scores are legitimate but softer than objective measures. Both matter; they are not the same.
- Is the negative evidence mentioned? This is the fastest tell. A brand that names the trials that went against it is telling you how it handles inconvenient facts.
Why studies disagree
Three ordinary reasons, none of them conspiracy. Dosage varies enormously between trials, and some null results may simply have used too little. Delivery method matters — skin and digestion are different routes. And individual response varies, while trials report averages, which is why a study result never predicts one person's experience.
There is also a quality problem specific to this category. Independent testing of retail CBD has repeatedly found products containing less CBD than labeled. A study using verified material is not testing the same thing as an underdosed product on a shelf. That gap is exactly why a Certificate of Analysis matters more than a citation.
Apply this to us
We would rather you held K61 to this standard than took our word for anything. So, plainly: we are not going to tell you what our products will do for you. We will tell you what is in them, show you the third-party lab report for your specific batch, and let you decide.
If you want to test something for yourself, the sensible approach is the one researchers use — pick one product, use it consistently for two weeks, and write down what you notice. Your own notes are better evidence for you than anyone's study.
Read Our Lab Reports
Every K61 batch is third-party tested and every Certificate of Analysis is published, tied to the batch number on your jar. Check before you trust — ours or anyone's.
View Lab ResultsImportant: This article describes published research for general educational purposes and makes no claim about what any product will do for you. These statements have not been evaluated by the Food and Drug Administration. K61 products are not intended to diagnose, treat, cure, or prevent any disease. Talk with your physician about any health condition. 21+.
